A photo of Marc Schecter.

Clinical Director, Pediatric Lung Transplant Program

Professor, UC Department of Pediatrics

513-636-6771

Board Certified

Best Doctors logo

My Biography & Research

Biography

While I always knew that I wanted to be a doctor and help people, it was late in medical school that I decided to be a pediatrician. I found it rewarding that working with and educating children can have a significant impact on their lives. I still love seeing my patients every day.

One of my mentors encouraged me to consider transplant care, as I enjoyed the complexity, multidisciplinary care and helping the sickest of the sick. As a lung specialist, I care for children and adolescents with lung disease, lung failure and those who need lung transplantation. I serve on the Board of Directors of the United Network of Organ Sharing (UNOS) and the Organ Procurement and Transplant Network (OPTN).

I am the clinical director of our Pediatric Lung Transplant Program, which provides comprehensive care to those children with end-stage lung disease that cannot be cured with medicines or surgery. While we cannot transplant every child, the lung transplant team and I will give families our time, energy and the best care possible to the child. We take care of the entire patient from the top of their head to the bottom of their feet. While we focus on the lungs, everything else may be just as important. I give my patients all the time that they need.

In my research, my colleagues and I are seeking ways to have better clinical outcomes for pediatric lung transplant patients.

Outside the hospital, I enjoy spending time with my family and dogs. I like tennis and was a state champion and collegiate athlete.

Academic Affiliation

Professor, UC Department of Pediatrics

Clinical Divisions

Pulmonary Medicine, Lung Transplant, Heart, Fontan Management

Research Divisions

Pulmonary Medicine

My Locations

My Education

MD: University of Texas Medical Branch, Galveston, TX, 2000.

Residency: University of Texas Health Science Center, Houston, TX, 2003.

Fellowship: University of Texas Health Science Center, Houston, TX, 2006.

Certifications: Pediatrics, 2003; Pediatric Pulmonary, 2006.

My Publications

Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation. Coiffard, B; Prud'Homme, E; Hraiech, S; Cassir, N; Le Pavec, J; Kessler, R; Meloni, F; Leone, M; Thomas, PA; Reynaud-Gaubert, M; et al. BMC Pulmonary Medicine. 2020; 20.

International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation. Martinu, T; Koutsokera, A; Benden, C; Cantu, E; Chambers, D; Cypel, M; Edelman, J; Emtiazjoo, A; Fisher, AJ; Greenland, JR; et al. Journal of Heart and Lung Transplantation. 2020; 39:1171-1190.

Pediatric heart-lung transplantation: A contemporary analysis of outcomes. Riggs, KW; Chapman, JL; Schecter, M; Towe, C; Zafar, F; Morales, DL S. Pediatric Transplantation. 2020; 24.

Evaluation of a change in cytomegalovirus prevention strategy following pediatric solid organ transplantation. Pangonis, S; Paulsen, G; Andersen, H; Flores, F; Miethke, A; Peters, A; Kocoshis, S; Lazear, D; Garr, B; Schecter, M; et al. Transplant Infectious Disease. 2020; 22.

Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study. Sweet, SC; Chin, H; Conrad, C; Hayes, D; Heeger, PS; Faro, A; Goldfarb, S; Melicoff-Portillo, E; Mohanakumar, T; Odim, J; et al. American Journal of Transplantation. 2019; 19:3284-3298.

Perceived barriers to medication adherence remain stable following solid organ transplantation. Danziger-Isakov, L; Frazier, TW; Worley, S; Williams, N; Shellmer, D; Dharnidharka, VR; Gupta, NA; Ikle, D; Shemesh, E; Sweet, SC; et al. Pediatric Transplantation. 2019; 23.

Sequence of refusals for donor quality, organ utilization, and survival after lung transplantation. Singh, E; Schecter, M; Towe, C; Rizwan, R; III, RB; Tweddell, J; Hossain, MM; Morales, D; Zafar, F. Journal of Heart and Lung Transplantation. 2019; 38:35-42.

Anellovirus loads are associated with outcomes in pediatric lung transplantation. Blatter, JA; Sweet, SC; Conrad, C; Danziger-Isakov, LA; Faro, A; Goldfarb, SB; Jr, HD; Melicoff, E; Schecter, M; Storch, G; et al. Pediatric Transplantation. 2018; 22:e13069-e13069.

Risk and outcomes of pulmonary fungal infection after pediatric lung transplantation. Ammerman, E; Sweet, SC; Fenchel, M; Storch, GA; Conrad, C; Jr, HD; Faro, A; Goldfarb, S; Melicoff, E; Schecter, M; et al. Clinical Transplantation. 2017; 31.

Epstein-Barr viral loads do not predict post-transplant lymphoproliferative disorder in pediatric lung transplant recipients: A multicenter prospective cohort study. Parrish, A; Fenchel, M; Storch, GA; Buller, R; Mason, S; Williams, N; Ikle, D; Conrad, C; Faro, A; Goldfarb, S; et al. Pediatric Transplantation. 2017; 21:e13011-e13011.